Volume 65, Issue 6, Pages (June 2004)

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Volume 81, Issue 2, Pages (January 2012)
Volume 74, Issue 12, Pages (December 2008)
Long-term evolution of cardiomyopathy in dialysis patients
Volume 67, Issue 6, Pages (June 2005)
Volume 70, Issue 10, Pages (November 2006)
Volume 78, Issue 8, Pages (October 2010)
Propofol-related green urine
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use  Mei-Ling Blank, Lianne.
No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease  Kevin E. Chan, Ravi I. Thadhani,
Volume 86, Issue 6, Pages (December 2014)
Reassessment of the care of the patient with chronic kidney disease
Volume 74, Issue 12, Pages (December 2008)
Volume 80, Issue 10, Pages (November 2011)
Volume 84, Issue 2, Pages (August 2013)
Kumar Sharma, Ljiljana Paša-Tolić  Kidney International 
Burden of chronic kidney disease: North Africa
Volume 69, Issue 8, Pages (April 2006)
Rutger J.H. Maas, Jack F.M. Wetzels, Jeroen K.J. Deegens
Is there a pharmacologic basis for combination renin axis blockade?
Volume 78, Issue 12, Pages (December 2010)
Volume 65, Issue 2, Pages (February 2004)
Serum-soluble urokinase receptor concentration in primary FSGS
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 70, Issue 11, Pages (December 2006)
Volume 78, Issue 5, Pages (September 2010)
Volume 57, Issue 1, Pages (January 2000)
Volume 73, Issue 11, Pages (June 2008)
Volume 64, Issue 4, Pages (October 2003)
Volume 71, Issue 6, Pages (March 2007)
Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon 
Volume 70, Issue 12, Pages (December 2006)
Synaptopodin expression in idiopathic nephrotic syndrome of childhood
Volume 61, Issue 1, Pages (January 2002)
Fructose intake as a risk factor for kidney stone disease
Response to ‘Hepcidin levels in patients with renal disease’
HIV-related nephropathy: A South African perspective
Volume 69, Issue 5, Pages (March 2006)
Volume 72, Issue 12, Pages (December 2007)
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate  N. Takahashi, G. Boysen, F.
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 64, Issue 1, Pages (July 2003)
Volume 93, Issue 1, Pages (January 2018)
Long-term evolution of cardiomyopathy in dialysis patients
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
The initiation and progression of sickle cell nephropathy
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Unilateral renal cystic disease
Volume 82, Issue 9, Pages (November 2012)
Endothelin antagonists in renal disease
Volume 65, Issue 6, Pages (June 2004)
Volume 55, Pages S3-S16 (June 1999)
Volume 67, Issue 6, Pages (June 2005)
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
Is complement a target for therapy in renal disease?
Volume 70, Issue 10, Pages (November 2006)
Volume 55, Pages S41-S46 (June 1999)
Volume 77, Issue 12, Pages (June 2010)
Volume 56, Issue 6, Pages (December 1999)
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Presentation transcript:

Volume 65, Issue 6, Pages 2426-2434 (June 2004) Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes  Eva M. Weissinger, Stefan Wittke, Thorsten Kaiser, Hermann Haller, Sebastian Bartel, Ronald Krebs, Igor Golovko, Harald D. Rupprecht, Marion Haubitz, Hartmut Hecker, Harald Mischak, Danilo Fliser  Kidney International  Volume 65, Issue 6, Pages 2426-2434 (June 2004) DOI: 10.1111/j.1523-1755.2004.00659.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 The MosaiquesVisu software allows the depiction of the information from a crude capillary electroporesis-mass spectrometry analysis. A three-dimensional contour plot of urine from a healthy volunteer is shown, mass per charge on the Y-axis against the retention time in min (X-axis), signal intensity color coded (A, left side). Next, the signal-to-noise is calculated and the noise removed, thus leaving only actual signals (B). The software calculates the actual mass based on both isotopic distribution and conjugated masses (C). This results in a table of up to 1500 polypeptides defined via their mass and retention time. As an example, bottom right shows 17 polypeptides found in the sample. Kidney International 2004 65, 2426-2434DOI: (10.1111/j.1523-1755.2004.00659.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 The contour plots of polypeptides (actual masses) for healthy subjects (NC) and for patients with focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), and membranous glomerulonephritis (MGN) are shown. The upper mass limit is indicated on the top left of each plot. As evident, the contour plots differ significantly between the healthy subjects and the renal disease groups. Kidney International 2004 65, 2426-2434DOI: (10.1111/j.1523-1755.2004.00659.x) Copyright © 2004 International Society of Nephrology Terms and Conditions